Single Pass Announces Successful Initiation of Clinical Evaluation
Single Pass, Inc. CEO, Bill Colone, the initiation of the clinical evaluation for the Kronos Electrocautery device designed to improve the safety of co-axial biopsy procedures.
Latest Press Releases
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly.
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
NaNotics to Collaborate with Mass General Cancer Center
NaNotics LLC, a biopharmaceutical company developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood.
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend
Fresenius Kabi, a global health care company that specializes in pharmaceuticals, medical technologies, and nutrition products for critical and chronic conditions.
superpowered Robot Scientist for autonomously intelligent NGS delivery
Novogene at the forefront of cutting-edge next-generation sequencing (NGS) services, has officially Falcon II, a superpowered robot scientist for autonomously intelligent NGS delivery.
Sucraid® (sacrosidase) Oral Solution single-use containers for patients
QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid®.
Global High Potent Manufacturing Services Supporting Oncology Treatments
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), a significant expansion of its world-class facility in Tredegar, Wales, UK, designed to help keep pace with the market growth of powerful, targeted oncology therapies.
Advanced Instruments Introduces the OsmoPRO®
Advanced Instruments at the American Association for Clinical Chemistry trade show in Chicago the newest addition to its clinical line of freezing point osmometers, the OsmoPRO MAX Automated Osmometer.
Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection
Fresenius Kabi the immediate availability in the U.S. of Glycopyrrolate Injection, USP in 0.6 mg per 3 mL Simplist® ready-to-administer prefilled syringes.
Daewoong Pharmaceutical New Idiopathic Pulmonary Fibrosis Drug
As many Korean pharmaceutical manufacturers are currently attempting to develop new drugs for idiopathic pulmonary fibrosis, Daewoong Pharmaceutical's new medication.
Abbisko Therapeutics Completed Dosing of First Patient
Abbisko Therapeutics Co., Ltd. (HKEX Stock Code: 2256.HK, referred to "Abbisko Therapeutics" hereafter) completion of dosing of the first patient in the Phase.